AzTrials
AzTrials

Shock StateCRIPINCT07555041

Correlation Between Capillary Refill Time and Perfusion Index in Critically Ill Patients

An observational study of Shock State and Hemodynamics Instability, run by Hospices Civils de Lyon at 2 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Assessment of capillary refill time (CRT) is a cornerstone of tissue perfusion monitoring in critically ill patients. CRT measurement is performed by applying brief and gentle pressure (for a few seconds) to a small area of skin until blanching occurs. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Microcirculation monitoring
How many people
267 participants
Where
2 sitesFrance
Study dates
29 Apr 2026to 29 Sep 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients admitted to a University Hospital, either to a medical or surgical intensive care unit.

Who may be able to join

  • Adult patient.
  • Admission within the previous 24 hours, or within 24 hours of the onset of a hemodynamic instability criterion (requirement for vasopressors or fluid resuscitation).
  • Absence of patient objection.

Who cannot join

  • Legal guardianship, curatorship, or judicial protection.
  • No social security coverage.
  • Morphological abnormalities preventing CRT and IP measurements.

Trial locations and contacts

2 sites in 1 country.

France2 sites
  • Service de Réanimation cardio-vasculaire et thoracique, Hôpital Cardiologique louis Pradel, Hospices Civils de Lyon

    Bron, 69500

  • Service de Médecine Intensive-Réanimation, Hôpital Édouard Herriot, Hospices Civils de Lyon

    Lyon, 69003

Other trials in France

About this study

Official title: Correlation Between Capillary Refilling tIme and Perfusion Index in Critically Ill Patients

Assessment of capillary refill time (CRT) is a cornerstone of tissue perfusion monitoring in critically ill patients.

CRT measurement is performed by applying brief and gentle pressure (for a few seconds) to a small area of skin until blanching occurs. CRT is defined as the time, in seconds, required for the skin surface to return to its initial color after release of pressure.

Read more

Although CRT is a monitoring tool used on a daily basis in emergency departments and critical care units, its practical measurement modalities remain poorly standardized and time-consuming. Consequently, there is no consensus regarding the most reproducible bedside method for CRT assessment. Moreover, repeated CRT measurements during patient management are resource-intensive in terms of medical time and may raise issues related to healthcare staff availability.

The perfusion index (PI) is a marker of tissue perfusion derived from a pulse oximetry sensor. This monitoring device is routinely used in all critically ill patients. It is placed on the finger and worn continuously, including during patient transport.

Because PI measurement is automatic and continuous, establishing its correlation with CRT could allow for more precise tissue perfusion monitoring while reducing the time burden associated with bedside assessments in critically ill patients.

Being tested
Microcirculation monitoring
Keywords
Capillary refill time, Perfusion index, Microcirculation, Intensive care

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Microcirculation monitoringOther

    Also called Capillary refill time (CRT) measurements

    Microcirculation monitoring by Capillary Refill Time (CRT) measurements

  • Microcirculation monitoringOther

    Also called Perfusion index (PI) measurements

    Microcirculation monitoring by Perfusion Index (PI) measurements

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Perfusion index (PI) threshold associated with abnormal capillary refill time (CRT)

    The primary endpoint will be the PI threshold associated with abnormal CRT (> 3 seconds).

    CRT is measured in seconds and PI in arbitrary units. These parameters will be measured simultaneously on each patient.

    Measurements will be performed at the inclusion of each patient.

    Measured: At the inclusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Apr 2026
  2. Study start29 Apr 2026
  3. Primary completion29 Sep 2026
  4. Study completion29 Sep 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
267 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07555041
Sponsor's protocol ID
69HCL26_0232
Acronym
CRIPI
Status last verified
Oct 2026
First submitted
21 Apr 2026
Last updated
2 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Shock State and Hemodynamics Instability, run by Hospices Civils de Lyon at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Perfusion index (PI) threshold associated with abnormal capillary refill time (CRT) (time frame: At the inclusion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2026; AzTrials last refreshed its copy on 28 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in